Are multiple mechanisms involved in FTLD-TDP pathologensis: will one drug fit all?
Status / Stage
CompletedDates
1 February 2016 -31 January 2020
Duration (calculated)
03 years 11 monthsFunder(s)
Alzheimer's Research UKFunding Amount
£419,995.00Funder/Grant study page
Alzheimer's Research UKContracted Centre
University College LondonPrincipal Investigator
Dr Tammaryn LashleyPI Contact
t.lashley@ucl.ac.ukWHO Catergories
Understanding risk factorsUnderstanding Underlying Disease
Disease Type
Frontotemporal Dementia (FTD)CPEC Review Info
Reference ID | 229 |
---|---|
Researcher | Reside Team |
Published | 12/06/2023 |
Data
Status / Stage | Completed |
---|---|
Start Date | 20160201 |
End Date | 20200131 |
Duration (calculated) | 03 years 11 months |
Funder/Grant study page | Alzheimer's Research UK |
Contracted Centre | University College London |
Funding Amount | £419,995.00 |
Aims
Investigating one of the hallmark proteins of frontotemporal dementia.Dr Tammaryn Lashley will tease apart this complexity, zeroing in on the key changes that cause nerve cells to die. The team is focusing on a particular protein called TDP-43, which is found in the brain in about half of those with FTD. Researchers don’t yet know all the different ways that TDP-43 can cause nerve cell damage, so understanding more about the key steps in the disease will help in the search for new treatments.